このコンテンツを視聴するには最新バージョンの Adobe Flash Player を利用していることが必要です。
: 2011-09-05- Evec signed the contract with Astellas Pharma Inc. , licensing one antibody for commercial development.
Astellas Pharma Inc. - : 2011-06-29
- Website was renewed.
- : 2010-01-22
- Kenzo Takada, MD, PhD received the Hokkaido Science and Technology Award.
: 2009-10-09- Evec had an exhibition at Bio Japan 2009（Oct 7- 9.）
- : 2009-06-05
- Evec received the Minister Award for Science, Technology and Innovation Policy of Japan at the 8th Business-Academia-Government Collaboration Summit (Kyoto, Jun. 20-21).
- : 2008-09-30
- Evec signed the contract with Boehringer Ingelheim GmbH (Germany), licensing one kind of antibody for commercial development.
Evec develops fully human antibodies with high affinity and less side effect, and provides them to companies seeking for antibody medicine, and jointly pursue further antibody development with allied partners.
Evec devised the technique, independent from the costly Western patents, to develop fully human antibodies from blood B lymphocytes, responsible for humoral immunity in human body.
